Stevens L M, Klinger H, Roberts E F. "一种恩格列净杂质121的合成方法" [P]. US Patent, US 9806138 B2, 2025-02-20.
发明人郑宇鹏,唐晓军,马晓峰. "Method for the Synthesis of Empagliflozin Impurity 121" [P]. 中国发明专利, 专利号 CN 112978942 B, 授权公告日 2022-02-01.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质121 in Pharmaceutical Formulations". Food Chem., 2018, 166, 2648-2659.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质121 as an Impurity". Chemosphere, 2021, 1760, (11), 2418-2429.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impurity 121 Using HRMS and NMR". Talanta, 2012, 2083, 8284-8308.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 恩格列净杂质121 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2024, 2115, 1788-1794.